ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Gilead Sciences


Include trials that are no longer recruiting patients.

33 studies were found.
1.CompletedCidofovir as a Treatment for Herpes Simplex in Patients with AIDS
Conditions: Herpes Simplex; HIV Infections
2.CompletedA Comparison of Two Drug Combinations Used in HIV-Infected Patients Who Never Have Taken Anti-HIV Drugs
Condition: HIV Infections
3.CompletedA Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV Infection
Condition: HIV Infections
4.RecruitingA Dose Escalation Study of GS-7340-02 in Treatment Naive Patients
Condition: HIV Infections
5.RecruitingEvaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients with Chronic Hepatitis B
Condition: Chronic Hepatitis B
6.CompletedHPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol
Conditions: Cytomegalovirus Retinitis; HIV Infections
7.CompletedA Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3
Condition: HIV Infections
8.RecruitingAn Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients with Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options
Condition: Chronic Hepatitis B
9.CompletedAn Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS
Conditions: Cytomegalovirus Retinitis; HIV Infections
10.CompletedPhase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)phosphonylmethoxyethyl]adenine (bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected Patients
Condition: HIV Infections
11.CompletedA Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-phosphonylmethoxypropyl)cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDS
Conditions: Herpes Simplex; HIV Infections
12.CompletedA Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of 9-(2-Phosphonylmethoxyethyl)adenine ( PMEA; Adefovir ) in Patients With Advanced HIV Disease.
Condition: HIV Infections
13.CompletedA Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies with Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient
Condition: HIV Infections
14.No longer recruitingSafety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children
Condition: HIV Infections
15.CompletedSafety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected Patients
Condition: HIV Infections
16.CompletedThe Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined with Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
Condition: HIV Infections
17.CompletedThe Safety and Effectiveness of bis-POM PMEA in HIV-Infected Patients
Condition: HIV Infections
18.CompletedThe Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients with AIDS
Conditions: Cytomegalovirus Retinitis; HIV Infections
19.CompletedThe Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients
Conditions: HIV Infections; Condyloma Acuminata
20.CompletedSafety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations
Condition: HIV Infections
21.CompletedSafety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment
Condition: HIV Infections
22.No longer recruitingSafety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients
Condition: HIV Infections
23.No longer recruitingThe Safety and Effectiveness of PMPA Prodrug in HIV-Infected Patients
Condition: HIV Infections
24.CompletedSafety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected Patients
Condition: HIV Infections
25.CompletedThe Safety and Effectiveness of Zidovudine Plus Adefovir in HIV-Infected Patients
Condition: HIV Infections
26.RecruitingSafety and Efficacy of Adefovir Dipivoxil in Children and Adolescents with Chronic Hepatitis B
Condition: Chronic Hepatitis B
27.No longer recruitingThe Safety of Tenofovir Disoproxil Fumarate Taken with Other Anti-HIV Drugs to Treat HIV-Infected Patients
Condition: HIV Infections
28.CompletedA Study of Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Been Treated with Anti-HIV Drugs
Condition: HIV Infections
29.No longer recruitingA Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients with AIDS
Conditions: Cytomegalovirus Retinitis; HIV Infections
30.CompletedA Study of PMPA in HIV-Infected Patients
Condition: HIV Infections
31.CompletedA Study on the Safety and Effectiveness of Adefovir Dipivoxil in Combination with Anti-HIV Therapy (HAART) in HIV-Positive Patients
Condition: HIV Infections
32.CompletedTenofovir Disoproxil Fumarate (TDF) in HIV-1 Patients Who Have Never Taken Anti-HIV Drugs
Condition: HIV Infections
33.No longer recruitingTenofovir Disoproxil Fumarate in HIV-Infected Patients Who Have Not Had Success with Other Anti-HIV Drug Combinations
Condition: HIV Infections

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act